Security key
89455T109
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)
CUSIP: 89455T109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common stock, $0.001 par value
- Shares outstanding
- 64,609,137
- Total 13F shares
- 38,411,285
- Share change
- +491,805
- Total reported value
- $225,932,843
- Price per share
- $5.88
- Number of holders
- 122
- Value change
- +$594,572
- Number of buys
- 65
- Number of sells
- 69
Report period
Q2 2025
Institutions
122
Top holders
10
TMCI full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
TREACE MEDICAL CONCEPTS, INC. SEC filings
TREACE MEDICAL CONCEPTS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89455T109
Recent filing periods:
Top shareholders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
9.9%
from 13D/G
|
6,211,000
|
$52,110,290 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13D/G
13F
|
Company |
3.4%
|
2,091,809
|
$13,931,448 | $0 | 31 Dec 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
4.7%
|
3,060,612
|
$25,678,535 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
3.5%
|
2,293,523
|
$16,284,013 | — | 31 Mar 2025 | |
| GAGNON SECURITIES LLC |
13F
|
Company |
2.7%
|
1,746,536
|
$14,653,437 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2%
|
1,284,174
|
$10,774,219 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.4%
|
920,174
|
$7,720,260 | — | 31 Mar 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.1%
|
713,539
|
$5,986,592 | — | 31 Mar 2025 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
0.77%
|
498,924
|
$4,185,972 | — | 31 Mar 2025 | |
| Gagnon Advisors, LLC |
13F
|
Company |
0.76%
|
489,891
|
$4,110,185 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.72%
|
468,278
|
$3,928,852 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.69%
|
444,887
|
$3,732,602 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.6%
|
386,503
|
$3,242,759 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.59%
|
380,411
|
$3,191,648 | — | 31 Mar 2025 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.57%
|
365,393
|
$3,065,647 | — | 31 Mar 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.53%
|
343,490
|
$2,881,881 | — | 31 Mar 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.5%
|
493,584
|
$621,916 | — | 31 Mar 2025 | |
| Alphabet Inc. |
13F
|
Company |
0.46%
|
448,492
|
$565,100 | — | 31 Mar 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.45%
|
292,313
|
$2,452,506 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.42%
|
271,272
|
$2,275,972 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.4%
|
259,577
|
$2,177,851 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.39%
|
252,700
|
$2,120,153 | — | 31 Mar 2025 | |
| Lisanti Capital Growth, LLC |
13F
|
Company |
0.39%
|
252,215
|
$2,116,084 | — | 31 Mar 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.38%
|
244,800
|
$2,053,868 | — | 31 Mar 2025 | |
| Arcadia Wealth Management, Inc. |
13F
|
Company |
0.32%
|
209,972
|
$1,761,665 | — | 31 Mar 2025 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.31%
|
302,743
|
$411,730 | — | 31 Mar 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.29%
|
188,311
|
$1,579,934 | — | 31 Mar 2025 | |
| Birchview Capital, LP |
13F
|
Company |
0.26%
|
164,947
|
$1,383,905 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.24%
|
155,078
|
$1,301,104 | — | 31 Mar 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.23%
|
147,695
|
$1,239,161 | — | 31 Mar 2025 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.21%
|
136,407
|
$1,144,455 | — | 31 Mar 2025 | |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
0.21%
|
203,190
|
$256,019 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
126,800
|
$1,063,852 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.2%
|
126,457
|
$1,060,000 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
122,317
|
$1,026,239 | — | 31 Mar 2025 | |
| Accredited Investors Inc. |
13F
|
Company |
0.15%
|
100,000
|
$839,000 | — | 31 Mar 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.14%
|
92,500
|
$776,075 | — | 31 Mar 2025 | |
| KESTRA PRIVATE WEALTH SERVICES, LLC |
13F
|
Company |
0.14%
|
139,156
|
$175,337 | — | 31 Mar 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
85,465
|
$717,051 | — | 31 Mar 2025 | |
| PDT Partners, LLC |
13F
|
Company |
0.13%
|
84,499
|
$708,947 | — | 31 Mar 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.13%
|
84,300
|
$707,277 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.13%
|
82,489
|
$692,083 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.13%
|
81,303
|
$682,132 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.12%
|
74,875
|
$628,201 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.11%
|
71,642
|
$601,127 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.11%
|
69,916
|
$586,585 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.11%
|
68,251
|
$572,628 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.1%
|
66,748
|
$560,016 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
58,523
|
$491,008 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.09%
|
58,150
|
$487,879 | — | 31 Mar 2025 |
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q2 2025
As of 30 Jun 2025,
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,411,285 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, GAGNON SECURITIES LLC, JPMORGAN CHASE & CO, CIBC Private Wealth Group LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
123
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
136
Q2 2025 holders
122
Holder diff
-14
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.